期刊文献+

HA纳米载体介导转hGM-CSF基因的HepG2疫苗诱导的抗瘤效应研究 被引量:2

Anti-tumor effects of HepG2 tumor vaccine transfected hGM-CSF gene mediated by HA nanoparticles
原文传递
导出
摘要 目的:观察HA纳米颗粒载体介导转染hGM-CSF基因的HepG2细胞疫苗体外抗肿瘤效应,为hGM-CSF基因修饰的HepG2细胞疫苗的临床应用提供依据。方法:HA纳米颗粒载体介导hGM-CSF基因转染HepG2细胞制备转GMCSF基因的HepG2细胞疫苗。密度梯度离心法分离人PBMC,体外诱导人PBMC。WST-1法测定PBMC的增殖活性及对HepG2细胞的杀伤效应,流式细胞术分析CD4+和CD8+的阳性表达率,ELISA法测定INF-γ的分泌。结果:WST-1结果显示,转基因HepG2组疫苗能诱导PBMC增殖,其增殖率优于野生型疫苗(p<0.05);其诱导的PBMC对HepG2的杀伤率高于各野生型疫苗组和各空白对照组(p<0.05)。FCM结果显示,转基因HepG2疫苗组PBMC中CD4+和CD8+阳性表达率均高于各野生型疫苗组和各空白对照组(p<0.05)。ELISA结果显示,转基因组PBMC培养上清中IFN-γ含量为1989.76±254.21pg/ml,高于各野生型疫苗组和各空白对照组(p<0.05)。结论:HA纳米颗粒载体介导转染hGM-CSF基因能增加HepG2细胞疫苗的免疫原性,转hGM-CSF基因HepG2细胞疫苗可有效诱导PBMC增殖、分化,增加INF-γ的分泌,提高其对HepG2细胞的杀伤作用。 Objective:To observe the HA Nanoparticles mediated transfection of hGM-CSF gene in HepG2 cells in vitro anti-tu-mor effect of the vaccine for the hGM-CSF gene-modified vaccine HepG2 cells provide the basis for clinical application.Methods:HA nanoparticles mediated gene transfer hGM-CSF preparation of HepG2 cells HepG2 cells transfected GMCSF gene vaccine.Density gra-dient centrifugation were PBMC,in vitro induction of human PBMC.WST-1 method PBMC proliferation activity and killing effect on HepG2 cells,flow cytometry analysis of CD4+and CD8+ positive expression rates,ELISA determination of INF-γ secretion.Results:WST-1 showed that transgenic HepG2 group of vaccine induced PBMC proliferation,the proliferation rate than wild-type vaccine(p0.05).The PBMC of the HepG2 induced high anti-vaccine groups in the wild type and the control group(p0.05).FCM results showed that transgenic HepG2 PBMC in the vaccine group CD4+and CD8+expression was higher than the wild-type vaccine group and con-trol group(p0.05).ELISA results showed that the transgenic group PBMC supernatants of IFN-γ content was 1989.76±254.21 pg/ml,higher than the wild-type vaccine group and control group(p0.05).Conclusion:HA nanoparticles mediated transfection of hGM-CSF gene can increase the immunogenicity of the vaccine HepG2 cells,transfected HepG2 cells in hGM-CSF gene vaccine can effectively induce PBMC proliferation,differentiation,increased INF-γ secretion,increase its HepG2 cells in vitro.
出处 《现代生物医学进展》 CAS 2011年第4期672-676,671,共6页 Progress in Modern Biomedicine
基金 湖南省卫生厅科研基金资助项目(B2005-178)
关键词 肝肿瘤 肿瘤疫苗 免疫治疗 粒细胞巨噬细胞集落刺激因子 外周血单个核细胞 liver neoplasms tumor vaccine immune therapy granulocyte-macrophage colony-stimulating factor peripheral blood mononuclear cells
  • 相关文献

参考文献14

  • 1Wakai, T., et al., Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma [J]. Eur J Surg Oncol, 2003, 29(3): 266-71.
  • 2Tepper RI, Mule JJ. Experimental and clinical studies ofeytokine gene2modified tumor cells[J].Hum Gene Ther, 1994,5(2): 153-164.
  • 3Pardoll DM. Paracrine cytokine adjuvants in caneerimmunotherapy. [J]. Annu Rev Immunol, 1995, 13:339-415.
  • 4Morita T, Ikeda K, Douzona M, et al. Tumor Vaccination withmacrophage colony-stimulating factor producing Lewis lungcarcinoma in mice[J]. Blood, 1996,88(3):955-961.
  • 5郭淦华,段晓明,刘晓宇,曹建国,贺修胜.羟基磷灰石纳米颗粒载体介导hGM-CSF基因转染HepG2细胞及对其生长的影响[J].肿瘤,2008,28(3):224-227. 被引量:12
  • 6杜英,吴宏超,何非,张培东,王世祥,雷霄,吴翔.阿托伐他汀对脂多糖刺激下PBMC分泌TNFα-、IL-1β的影响[J].山东医药,2009,49(20):10-12. 被引量:1
  • 7Ulmer, J.B., B. Wahren, and M.A. Liu, Gene-based vaccines: recent technical and clinical advances [J]. Trends Mol Med, 2006, 12(5): 216-22.
  • 8Hege, K.M., K. Jooss, and D. Pardoll, GM-CSF gene-modifed cancer cell immunotherapies: of mice and men [J]. Int Rev Immunol, 2006, 25(5-6): 321-52.
  • 9Eager, R. and J. Nemtmaitis, GM-CSF gene-transduced tumor vaccines [J]. Mol Ther, 2005,12(1): 18-27.
  • 10Soiffer, R., et al., Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colonystimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma [J]. J Clin Oncol, 2003, 21(17): 3343-50.

二级参考文献28

  • 1朱晒红,周科朝,黄伯云,黄苏萍,刘芳,李益民,薛志刚,龙志高.羟基磷灰石纳米颗粒:一种新型基因转染载体材料[J].生物医学工程学杂志,2005,22(5):980-984. 被引量:23
  • 2Van Aelst L,D'Souza-Schorey C.Rho GTPases and signaling networks[J].Genes Dev,1997,11(18):2295-2322.
  • 3Mackay DJ,Hall A.Rho GTPases[J].J Biol Chem,1998,273(33):20685-20688.
  • 4Blank N,Schiller M,Krienke S,et al.Atorvastatin inhibits T cell activation through 3-Hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis[J].The Journal of Immunology,2007,179(6):3613-3621.
  • 5Wibaut-Berlaimont V,Randi AM,Mandryko V,et al.Atorvastatin affects leukocyte gene expression in dyslipidemia patients:in vivo regulation of hemostasis,inflammation and apoptosis[J].J Thromb Haemost,2005,3(4):677-685.
  • 6Rider PM,Rifai N,Pfeffer MA,et al.Inflammation,pravastatin,and the risk of coronary event after myocardial infarction in patientswith average cholesterol levels:the cholesterol and recurrent events(CARE) investigatiors[J].Circulation,1998,98(9):839-844.
  • 7Holm T,Andreassen AK,Ueland T,et al.Effect of pravastatin on plasma markers of inflammation and peripheralendothelial function in male heart transplant recipients[J].Am J Cardiol,2001,87(6):815-818.
  • 8Bonetti PO,Lerman LO,Napoli C,et al.Statin effects beyond lipid lowering -are they clinically relevant[J].Eur Heart J,2003,24(3):225-248.
  • 9Libby P,Aikawa M.Effects of statins in reducing thrombotic risk and modulating plaque vulnerability[J].Clin Cardiol,2003,26(1 Suppl 1):Ⅰ11-Ⅰ14.
  • 10姜泊 张亚历 周殿元.分子生物学常用实验方法[M].北京:人民军医出版社,2000..

共引文献14

同被引文献25

  • 1殷晓煜,黄嘉凌,吕明德,梁力建,周才明,黄洁夫.SCID鼠人肝癌皮下移植及免疫重建复合模型的建立[J].中华肝胆外科杂志,2004,10(3):184-186. 被引量:4
  • 2Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity [J]. Proc Natl Acad Sci USA,1993,90 (9):3 539-3543.
  • 3Soiffer R, Hodi FS, Haluska F, et al. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocytemacrophage colony-stimulating fator by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma [J]. J Clin Oncol,2003,21:3343-3350.
  • 4Tanii K, Azuma M, Nakazaki Y, et al. Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage Ⅳ renal cell cancer in Japan:clinical and immunological findings[J]. Mol Ther,2004,10:799-816.
  • 5Nemunaitis J, Sterman D, Jablon D, et al. Granulocyte-macrophage colony-stimulating fator gene-modified autologous tumor vaccines in non-small-cell lung cancer[J]. J Natl Cancer Inst,2004,96:326-331.
  • 6Nagai H, Miyaki D, Mastsui T, et al. Th1/Th2 balance.an important indicator of efficacy for intra-arterial chemotherapy [J]. Cancer Chem other Phamacol,2008,62(6):959-963.
  • 7Sharma A, Rajappa M, Satyam A, et al. Cytokines (TH1 and TH2) in patientswith advanced cervical cancerundergoing neoad-juvant chemoradiation: correlationwith treatment response[J]. IntJGyneeolCancer, 2009,19(7):1269-1275.
  • 8Tassi E, BragaM, Longhi R. Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of eareinoembryonieantigen specific CD4 T cells from pancreatic cancer patients [J]. PLoS One,2009,4 (10):7234-7239.
  • 9NonakaK, SaioM, Suwa T, et al. Skewing the Th cell phenotype tow- ard Th1 alters thematuration of tumor-infiltratingmononuclc-ar phagocytes[J]. J Lcukoc Biol,2008,84(3):679-688.
  • 10Wu J, Lu Y, Ding YB, et al. Promoter polymorphisms of IL2, IIA, and risk ofgastric cancer in a high-riskChinese population[J]. Mol Carcinog, 2009,48(7):626-632.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部